Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 9,494 shares at $28.06 ($266K) on 2024-07-09, disclosed to the SEC on 2024-07-10.
Open-market sale of $266k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.06 | 4,747 | $133K | 50.0% |
| 2 | $28.06 | 4,747 | $133K | 50.0% |
| Total | $28.06 avg | 9,494 | $266K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |